hrs4r
 I want to donate

The Nephrology Group aims to develop renal substitutive home treatments, mainly peritoneal dialysis. It also studies the macrovascular and microvascular affectation of inflammatory markers and mineral metabolism markers in chronic kidney disease and its most frequent pathologies: arterial hypertension and diabetic nephropathy.

Main lines of research

Study of macrovascular and microvascular involvement, inflammatory markers and markers of mineral metabolism in chronic kidney disease and its most frequent pathologies: arterial hypertension and diabetic nephropathy.

Strategic objectives

Consolidar la metodologia d’estudi del risc cardiovascular i la càrrega ateromatosa del pacients amb malaltia renal crònica, hipertensió arterial i diabetis mellitus amb nefropatia diabètica.

Publications
0

Multi-organ involvement and intratubular calcium phosphate deposition in the kidney biopsy: what should we investigate?

EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2022, 27, 2931-2935 dx.doi.org/10.1007/s40519-022-01406-6

Caravaca-Fontán F, Trujillo H, Alonso M, Díaz-Encarnación M, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez E, de la Cerda F, Pérez de José A, López I, Fernández L, Gómez VP, Ávila A, Bravo L, Lumbreras J, Allende N, Sanchez de la Nieta MD, Olea T, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, González F, Shabaka A, Illescas ML, Calvo C, Oviedo V, Da Silva I, Goicoechea de Jorge E, Caravaca F, Praga M, C3G Study Group of the Spanish Group for the Study of Glomerular Diseases (GLOSE

Validation of a Histologic Scoring Index for C3 Glomerulopathy.

AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77, 684 dx.doi.org/10.1053/j.ajkd.2020.11.011

Pilco Teran M, Merino Ribas A, Martin Alemany N, Barros Freiria X, Rubio Casadevall J, Pérez Bueno F, García Méndez I, Castillo Devia M, Noboa Paez C, Torguet Escuder P, Calabia Martínez J

Acute tubulointerstitial nephritis induced by the tyrosine kinase inhibitor vandetanib.

INVESTIGATIONAL NEW DRUGS, 2021, 39, 237-239 dx.doi.org/10.1007/s10637-020-00973-8
0

Characterization of Oral Enterobacteriaceae Prevalence and Resistance Profile in Chronic Kidney Disease Patients Undergoing Peritoneal Dialysis.

FRONTIERS IN MICROBIOLOGY, 2021, 12, 736685-736685 dx.doi.org/10.3389/fmicb.2021.736685

Caravaca-Fontán F, Díaz-Encarnación MM, Lucientes L, Cavero T, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez A, Pérez de José A, Rabasco C, Rodado R, Fernández L, Pérez Gómez V, Ávila AI, Bravo L, Lumbreras J, Allende N, Sanchez de la Nieta MD, Rodríguez E, Olea T, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, Cano-Megías M, González F, Shabaka A, López-Rubio ME, Fenollosa MÁ, Martín-Penagos L, Da Silva I, Alonso Titos J, Rodríguez de Córdoba S, Goicoechea de Jorge E, Praga M, Spanish Group for the Study of Glomerular Diseases GLOSEN

Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.

Clinical Journal Of The American Society Of Nephrology, 2020, 15, 1287-1298 dx.doi.org/10.2215/CJN.15241219

Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Robles NR, Agraz I, Poch E, Rodas L, Lozano V, Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García N, Goicoechea M, Calero F, Bonet J, Galceran JM, Liaño F, Pascual J, Praga M, Fulladosa X, Soler MJ

Risk factors for non-diabetic renal disease in diabetic patients.

CLINICAL KIDNEY JOURNAL, 2020, 13, 380-388 dx.doi.org/10.1093/ckj/sfz177

Corredor Z, Filho MIDS, Rodríguez-Ribera L, Velázquez A, Hernández A, Catalano C, Hemminki K, Coll E, Silva I, Diaz JM, Ballarin J, Vallés Prats M, Calabia Martínez J, Försti A, Marcos R, Pastor S

Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population.

SCIENTIFIC REPORTS, 2020, 10, 144-144 dx.doi.org/10.1038/s41598-019-56695-2

Rivera Gorrín M, Sosa Barrios RH, Ruiz-Zorrilla López C, Fernández JM, Marrero Robayna S, Ibeas López J, Salgueira Lazo M, Moyano Franco MJ, Narváez Mejía C, Ceballos Guerrero M, Calabia Martínez J, García Herrera AL, Roca Tey R, Paraíso Cuevas V, Merino Rivas JL, Abuward Abu-Sharkh I, Betriu Bars À

Consensus document for ultrasound training in the specialty of Nephrology.

Nefrologia, 2020, 40, 623-633 dx.doi.org/10.1016/j.nefro.2020.05.008

Hueso M, de Haro L, Calabia J, Dal-Ré R, Tebé C, Gibert K, Cruzado JM, Vellido A

Leveraging Data Science for a Personalized Haemodialysis.

Kidney Diseases, 2020, 6, 385-394 dx.doi.org/10.1159/000507291

Rodas LM, Matas-García A, Barros X, Blasco M, Viñas O, Llobell A, Martin N, Quintana LF

Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy.

CLINICAL KIDNEY JOURNAL, 2019, 12, 36-41 dx.doi.org/10.1093/ckj/sfy005
Competitive projects
Codi oficial: MICROPOLI Start date:11/08/2021 Data fi: 11/08/2026 Investigador/a principal: ANA MERINO RIBAS Organisme finançador: FUNDACIÓN SENEFRO Ajuda: 0 €
Job offers

Team

Group leader - R4

Predoctorals researchers – R1

Collaborators

Research technicians

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

menu